Search by Drug Name or NDC
NDC 69367-0245-16 Sodium Sulfacetamide and Sulfur 80; 40 mg/mL; mg/mL Details
Sodium Sulfacetamide and Sulfur 80; 40 mg/mL; mg/mL
Sodium Sulfacetamide and Sulfur is a TOPICAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Westminster Pharmaceuticals, LLC. The primary component is SULFACETAMIDE SODIUM; SULFUR.
Product Information
| NDC | 69367-0245 |
|---|---|
| Product ID | 69367-245_7ad361e4-dfcb-4af3-83f7-5716cf1861ec |
| Associated GPIs | 90059903201810 |
| GCN Sequence Number | 066791 |
| GCN Sequence Number Description | sulfacetamide sodium/sulfur SUSPENSION 8 %-4 % TOPICAL |
| HIC3 | Q5S |
| HIC3 Description | TOPICAL SULFONAMIDES |
| GCN | 29180 |
| HICL Sequence Number | 003344 |
| HICL Sequence Number Description | SULFACETAMIDE SODIUM/SULFUR |
| Brand/Generic | Generic |
| Proprietary Name | Sodium Sulfacetamide and Sulfur |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sodium Sulfacetamide and Sulfur |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | TOPICAL |
| Active Ingredient Strength | 80; 40 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | SULFACETAMIDE SODIUM; SULFUR |
| Labeler Name | Westminster Pharmaceuticals, LLC |
| Pharmaceutical Class | Sulfonamide Antibacterial [EPC], Sulfonamides [CS] |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69367-0245-16 (69367024516)
| NDC Package Code | 69367-245-16 |
|---|---|
| Billing NDC | 69367024516 |
| Package | 473 mL in 1 BOTTLE (69367-245-16) |
| Marketing Start Date | 2021-06-18 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.12448 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | SULFACETAMIDE-SULFUR 8-4% SUSP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis